ALPHS — Pharmasimple SA Income Statement
0.000.00%
Last trade - 00:00
TechnologyHighly SpeculativeMicro Cap
C2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | BAS | BAS | BAS | BAS | BAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.3 | 19.1 | 16.8 | 28.2 | 45.5 |
Cost of Revenue | |||||
Gross Profit | 1.94 | 3.12 | 3.17 | 4.96 | 10.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.1 | 20.4 | 19.1 | 31.3 | 46.9 |
Operating Profit | -0.741 | -1.29 | -2.32 | -3.03 | -1.38 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.942 | -1.37 | -2.44 | -3.18 | -1.53 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.941 | -1.37 | -2.44 | -3.19 | -1.53 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.941 | -1.37 | -2.44 | -3.17 | -1.52 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.941 | -1.37 | -2.44 | -3.17 | -1.52 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -33,801 | -44,618 | -94,565 | -53,937 | -24,846 |